Erythromycin labels and packages

Revision as of 22:58, 8 January 2014 by Chetan Lokhande (talk | contribs)
Jump to navigation Jump to search
Erythromycin
AKNE-MYCIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Labels And Packages

Jump to: navigation, search Bold textItalic textInternal linkExternal link (remember http:// prefix)Level 2 headlineEmbedded fileFile linkIgnore wiki formattingYour signature with timestampHorizontal line (use sparingly) PRINCIPAL DISPLAY PANEL - 25 g Tube Carton

Akne-mycin®2% (Erythromycin)

NDC 13548-030-25

Rx ONLY

FOR EXTERNAL USE ONLY

TOPICAL OINTMENT FOR ACNE

NET WT 25 g

CORIA® LABORATORIES, LTD.

[[File:|800px|thumb]]


[1]

References

  1. "AKNE-MYCIN (ERYTHROMYCIN) OINTMENT [CORIA LABORATORIES]".

Adapted from the FDA Package Insert.